Market Overview

Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS Estimates

Share:
Related NEOG
Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest ROI
Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Lowest PEG Ratio
Related ABAX
Medtronic Has Big Plans For This Device (And It Could Help 500,000 People Each Year)
Stocks Hitting 52-Week Highs
Next Week In Biotech: Amgen, AbbVie, Biogen Earnings, UniQure CHMP, AAN Meeting (Seeking Alpha)

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year.

Neogen (NASDAQ: NEOG) is likely to earn $1.30 per share in the next year ending May, 2014. Neogen's PEG ratio is 2.06.

Abaxis (NASDAQ: ABAX) may earn $1.11 per share in the next year ending March, 2014. Abaxis' trailing-twelve-month operating margin is 12.95%.

Trinity Biotech plc (NASDAQ: TRIB) is projected to earn $0.92 per share for the next year ending December, 2013. Trinity Biotech's trailing-twelve-month revenue is $80.67 million.

Meridian Bioscience (NASDAQ: VIVO) is expected to earn $0.88 per share over the next year ending September, 2013. Meridian Bioscience's trailing-twelve-month ROE is 22.58%.

Posted-In: Diagnostic Substances Industry Highest EPS Estimates small-capTrading Ideas

 

Related Articles (ABAX + NEOG)

Around the Web, We're Loving...

Get Benzinga's Newsletters